A Comparison between Open and Minimally Invasive Techniques for the Resection of Colorectal Liver Metastasis

Author:

Bartolini IleniaORCID,Fortuna LauraORCID,Risaliti MatteoORCID,Tirloni Luca,Buccianti Simone,Luceri CristinaORCID,Ringressi Maria Novella,Batignani GiacomoORCID,Taddei AntonioORCID

Abstract

The liver is the most common site of colorectal cancer metastasis. Liver surgery is a cornerstone in treatment, with progressive expansion of minimally invasive surgery (MIS). This study aims to compare short- and long-term outcomes of open surgery and MIS for the treatment of colorectal adenocarcinoma liver metastasis during the first three years of increasing caseload and implementation of MIS use in liver surgery. All patients treated between November 2018 and August 2021 at Careggi Teaching Hospital in Florence, Italy, were prospectively entered into a database and retrospectively reviewed. Fifty-one patients were resected (41 open, 10 MIS). Considering that patients with a significantly higher number of lesions underwent open surgery and operative results were similar, postoperative morbidity rate and length of hospital stay were significantly higher in the open group. No differences were found in the pathological specimen. The postoperative mortality rate was 2%. Mean overall survival and disease-free survival were 46 months (95% CI 42–50) and 22 months (95% CI 15.6–29), respectively. The use of minimally invasive techniques in liver surgery is safe and feasible if surgeons have adequate expertise. MIS and parenchymal sparing resections should be preferred whenever technically feasible.

Publisher

MDPI AG

Subject

Health Information Management,Health Informatics,Health Policy,Leadership and Management

Reference43 articles.

1. A randomized trial of laparoscopic versus open surgery for rectal cancer;Bonjer;N. Engl. J. Med.,2015

2. Cancer statistics, 2018;Siegel;CA Cancer J. Clin.,2018

3. Comparison of recurrence patterns between ≤5 years and >5 years after curative operations in colorectal cancer patients;Seo;J. Surg. Oncol.,2013

4. Colorectal cancer statistics, 2017;Siegel;CA Cancer J. Clin.,2017

5. Liver-directed therapies in metastatic colorectal cancer;Clark;J. Gastrointest. Oncol.,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3